Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description measured expected final
Results: HTML CSV LaTeX Showing element 1 to 50 of 350 in total
Hugo: 
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent final\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 4\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent 3.66001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3.3348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.097520091\vspace{3pt}}\\\cline{1-1}\cline{3-5} \parbox{\wcA}{\vspace{3pt}\noindent 17\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 0.0856348\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.180231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.475139127\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 28\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DOK-LIKE PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0753031\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.176719\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.426117735\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 32\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC (EC 2.7.1.112) (P60-SRC) (C-SRC). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.141847\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.33698\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.420935961\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 53\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DISKS LARGE-ASSOCIATED PROTEIN 2 (DAP-2) (SAP90/PSD-95-ASSOCIATED PROTEIN 2) (SAPAP2) (PSD-95/SAP90 BINDING PROTEIN 2) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.318849\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.775495\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.411155456\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 55\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.231369\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.562729\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.411155281\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 58\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent "DJ681N20.2 (NOVEL PROTEIN SIMILAR TO FERRITIN, LIGHT POLYPEPTIDE (FTL)). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0511645\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.124441\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.411154684\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 61\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PUTATIVE ADENOSYLHOMOCYSTEINASE 3 (EC 3.3.1.1) (S-ADENOSYL-L- HOMOCYSTEINE HYDROLASE) (ADOHCYASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.312681\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.760495\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.411154577\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 78\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ASPARTATE BETA-HYDROXYLASE ISOFORM B; JUNCTIN ISOFORM 1; JUNCTATE; ASPARTYL/ASPARAGINYL-BETA-HYDROXYLASE; PEPTIDE-ASPARTATE BETA-DIOXYGENASE; HUMBUG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.06383\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.157168\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.406125929\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 85\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TRANSCRIPTION FACTOR DP-1 (E2F DIMERIZATION PARTNER 1) (DRTF1- POLYPEPTIDE-1) (DRTF1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.788778\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2.02915\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.388723357\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 89\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.152828\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.396725\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.385224022\vspace{3pt}}\\\cline{1-1}\cline{3-5} \parbox{\wcA}{\vspace{3pt}\noindent 92\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 0.914796\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2.37847\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.38461532\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent UBA/UBX 33.3 KDA PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.375086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.05643\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.3550505\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ERO1-LIKE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0588477\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.165745\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.355049624\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE 4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.290469\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.826637\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.351386401\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent FORMIN BINDING PROTEIN 3; FAS-LIGAND ASSOCIATED FACTOR 1; HUNTINGTIN-INTERACTING PROTEIN A; NY-REN-6 ANTIGEN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.429285\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.22508\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.350413851\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 160\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HUNTINGTIN-INTERACTING PROTEIN HYPA/FBP11 (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.40616\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.16002\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.350131894\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent FILAMIN A (ALPHA-FILAMIN) (FILAMIN 1) (ENDOTHELIAL ACTIN-BINDING PROTEIN) (ABP-280) (NONMUSCLE FILAMIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0413389\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.122543\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.337341994\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TRINUCLEOTIDE REPEAT CONTAINING 15. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0561104\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.16661\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.336776904\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RD PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.155654\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.485577\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.320554721\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent JUN DIMERIZATION PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.193648\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.614336\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.315215127\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TRANSCRIPTION FACTOR BTF3 HOMOLOG 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.625831\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2.00343\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.312379769\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent NASCENT-POLYPEPTIDE-ASSOCIATED COMPLEX ALPHA POLYPEPTIDE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.804734\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2.57998\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.311914821\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ALPHA-NAC PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.755644\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2.42272\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.311899023\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.743299\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 2.38318\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.311893772\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 261\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent APOBEC-1 COMPLEMENTATION FACTOR ISOFORM 1; APOBEC-1 STIMULATING PROTEIN; APO-B RNA EDITING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0555455\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.180015\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.308560398\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 262\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0556846\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.180466\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.308560061\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 263\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RNA-BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0560669\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.181705\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.308560029\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 267\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.152054\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.494121\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.307726245\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 269\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SPLICING FACTOR 3B SUBUNIT 3 (SPLICEOSOME ASSOCIATED PROTEIN 130) (SAP 130) (SF3B130) (PRE-MRNA SPLICING FACTOR SF3B 130 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 1.08194\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 3.53138\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.306378809\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 287\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent "FATTY ACID-BINDING PROTEIN, EPIDERMAL (E-FABP) (PSORIASIS-ASSOCIATED FATTY ACID-BINDING PROTEIN HOMOLOG) (PA-FABP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0334849\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.110947\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.301809873\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 294\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent "BETA-CAROTENE DIOXYGENASE 2; PUTATIVE B,B-CAROTENE-9',10'-DIOXYGENASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0429558\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.142328\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.301808499\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 303\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HPAII TINY FRAGMENTS LOCUS 9C. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.20849\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.697153\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.299059174\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 304\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent UBIQUITIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.241123\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.807018\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.298782679\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 306\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ALPHA-1-ACID GLYCOPROTEIN 2 PRECURSOR (AGP 2) (OROSOMUCOID 2) (OMD 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.232016\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.784548\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.295732065\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MITOCHONDRIAL 28S RIBOSOMAL PROTEIN S32 (S32MT) (MRP-S32) (PTD007) (HSPC204). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0503334\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.170278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.295595438\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent BA395L14.12 (NOVEL PROTEIN SIMILAR TO SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE A' (SNRPA1)). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.482398\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.63545\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.294963466\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GA BINDING PROTEIN BETA-2 CHAIN (GABP-BETA-2 SUBUNIT) (TRANSCRIPTION FACTOR E4TF1-47) (GAPBP-2) (NUCLEAR RESPIRATORY FACTOR-2 SUBUNIT GAMMA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0373117\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.130845\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.28515954\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 347\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.135144\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.478436\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.282470383\vspace{3pt}}\\\cline{1-1}\cline{3-5} \parbox{\wcA}{\vspace{3pt}\noindent 356\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 0.0483186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.171674\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.281455549\vspace{3pt}}\\\cline{1-1}\cline{3-5} \parbox{\wcA}{\vspace{3pt}\noindent 357\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 0.042516\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.151058\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.281454805\vspace{3pt}}\\\cline{1-1}\cline{3-5} \parbox{\wcA}{\vspace{3pt}\noindent 373\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 0.034272\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.122748\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.279206179\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 40S RIBOSOMAL PROTEIN S26. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.135061\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.484774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.278606113\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.356784\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.28488\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.277678849\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DEAD (ASP-GLU-ALA-ASP) BOX POLYPEPTIDE 47; HQP0256 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0884193\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.318777\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.277370387\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TRANSFORMER-2 PROTEIN HOMOLOG (TRA-2 ALPHA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.345566\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 1.24774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.276953532\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 452\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent "PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1 (EC 3.1.3.48) (PROTEIN-TYROSINE PHOSPHATASE 1B) (PTP-1B). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.215243\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.779889\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.27599184\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 460\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent COLLAGEN ALPHA 5(IV) CHAIN PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0637349\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.231274\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.27558177699999997\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 492\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent 0.0344618\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.125634\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.274303135\vspace{3pt}}\\\cline{1-1}\cline{3-5} \parbox{\wcA}{\vspace{3pt}\noindent 498\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent 0.236585\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 0.862726\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 0.274229593\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots

- http://analysis.yellowcouch.org/